“Family means no one gets left behind or forgotten,” actor David Ogden Stiers once said. Those are words the CMTA lives by as we push hard every day to make sure no one in our CMT family gets left behind or forgotten. The goal of our Strategy to Accelerate Research (STAR) is to develop treatments for all types of CMT and the entire CMT family.
Although breakthroughs are often viewed as sudden, dramatic discoveries, they are actually the result of relentless hard work and determination. That’s what has been going on with Type 2 (download the update). Thanks to STAR and the support of two committed Type 2 families who are challenging the community to match $1.5 million in donations, we have set the stage for a number of Type 2 breakthroughs on our way to treatments for CMT. However, because of the crossover involved, we think many of these developments will also apply to Types 1 and 4 (which is why we also have matching gift challenges for those types).
The CMTA will need several million dollars to implement the strategies for developing these treatments, so if you or a loved one has Type 1, 2 or 4, we are asking you to help us as we keep reaching for our goals.
With your support and our relentless hard work and determination to bring treatments to you, we can force a breakthrough. Donate today! Do it for our family.
On behalf of the entire CMTA family, you have our sincere gratitude.
Amy Gray, CMTA Chief Executive Officer, and Jeana Sweeney, CMTA Director of Development